Fig. 1
Cassava transcriptome profiles in response to defense hormone treatments. a, b tDEG and gDEG counts in ECU72 and COL2246 during SA and JA treatments (0.5, 1, 2, 4, 8, 12, and 24 hpt). A visual definition of tDEGs and gDEGs is provided. Number of up- and down-regulated genes (red and blue, respectively) are displayed. Total number of DEGs for each treatment are provided. c PCAs of detected gene reads prior to and after SA and JA treatments (0, 0.5, 1, 2, 4, 8, 12, 24 hpt) in ECU72 and COL2246. Clustering of time points defined distinct early (E) and late (L) response phases in ECU72 versus COL2246 for which a visualization is provided. ECU72’s early phase (0–1 hpt) samples were more similar to COL2246’s late phase (4–12 hpt) and vice versa. Normalized read count values for three biological replicates are shown per time point. Time points and genotypes are labeled by color and shape, respectively. d Heatmaps displaying gDEGs in ECU72 and COL2246 in response to SA, JA, ET, and ABA treatments. Expression is displayed as log2FC values relative to 0 hpt. DEG expression values are provided in Additional file 1 and DEG counts in Additional file 2. DEGs had |log2FC|≥ 1 and FDR ≤ 5%